American Indian Chronic Renal Insufficiency Cohort Study (AI-CRIC Study)
Key facts
- Where
- Albuquerque, Black Rock, and Phoenix, United StatesSee the 3 sites
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 21 and 80 years old?
Source: NCT04185844, who can take part
Where in United States
- First Nations Community Health SourceAlbuquerque, United StatesTaking people
- Zuni Health Initiative CenterBlack Rock, United StatesTaking people
- NIDDK-Phoenix Epidemiology and Clinical ResearchPhoenix, United StatesNot yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University of New Mexico
- Trial code
- NCT04185844
- Record updated
- 13 October 2026
- Original description
Despite many advances in our understanding of the natural history and progression of chronic kidney disease (CKD) and cardio vascular disease (CVD) in the parent CRIC study over the past 15 years, important questions about key risk factors for these diseases remain unanswered in the AI population. To address this burden of CKD in AI communities Investigators formed a consortium of investigators with extensive experience in conducting research of chronic diseases including diabetes, cardiovascular and kidney disease in AIs of Southwestern US. The proposed CRIC ancillary cohort study of 500 AIs (AI-CRIC) will rapidly improve our understanding of both potential risk factors for CKD progression, as well as the scope of this disease among AIs. This study leverages the current CRIC study and incorporates the planned activities of the next phase of the study - "CRIC 2018" - by implementing contemporary CRIC protocols for kidney and cardiovascular measurement and outcomes.Read full original descriptionShow less
Despite many advances in our understanding of the natural history and progression of chronic kidney disease (CKD) and cardio vascular disease (CVD) in the parent CRIC study over the past 15 years, important questions about key risk factors for these diseases remain unanswered in the AI population. To address this burden of CKD in AI communities Investigators formed a consortium of investigators with extensive experience in conducting research of chronic diseases including diabetes, cardiovascular and kidney disease in AIs of Southwestern US. The proposed CRIC ancillary cohort study of 500 AIs (AI-CRIC) will rapidly improve our understanding of both potential risk factors for CKD progression, as well as the scope of this disease among AIs. This study leverages the current CRIC study and incorporates the planned activities of the next phase of the study - "CRIC 2018" - by implementing contemporary CRIC protocols for kidney and cardiovascular measurement and outcomes.
Inclusion: Glomerular Filtration Rate (GFR): eGFR of =>61<80 and microalbuminuria > 30 or eGRF of =<60 (no microalbuminuria required).
Exclusion: End stage renal disease or renal transplant; renal cancer; Polycystic kidney disease; life expectancy <3 years; Unable or unwilling to provide informed consent; institutionalized subjects; myeloma; immunosuppression; participation in any clinical trial,; current pregnancy; current incarceration; Appears unlikely or unable to participate in the required study procedures as assessed by the investigator, study coordinator or designee.